对布瓦等人的回复。关于“迪克斯特拉等人。1型酪氨酸血症新生儿筛查假阴性——需要重新评估使用琥珀酰丙酮进行的新生儿筛查。2023年，，66”的评论
Reply to Bouva et al. Comment on "Dijkstra et al. A False-Negative Newborn Screen for Tyrosinemia Type 1-Need for Re-Evaluation of Newborn Screening with Succinylacetone. 2023, , 66".
作者信息
Dijkstra Allysa M, Evers-van Vliet Kimber, Heiner-Fokkema M Rebecca, Bodewes Frank A J A, Bos Dennis K, Zsiros József, van Aerde Koen J, Koop Klaas, van Spronsen Francjan J, Lubout Charlotte M A
机构信息
Section of Metabolic Diseases, Beatrix Children's Hospital, University Medical Center Groningen, University of Groningen, 9700 RB Groningen, The Netherlands.
Laboratory of Metabolic Diseases, Department of Laboratory Medicine, University Medical Center Groningen, University of Groningen, 9700 RB Groningen, The Netherlands.
出版信息
Int J Neonatal Screen. 2024 Sep 24;10(4):66. doi: 10.3390/ijns10040066.
Abstract
We thank the authors for their comments [...].
摘要
我们感谢作者们的评论[...]。
相似文献
1
Reply to Bouva et al. Comment on "Dijkstra et al. A False-Negative Newborn Screen for Tyrosinemia Type 1-Need for Re-Evaluation of Newborn Screening with Succinylacetone. 2023, , 66".对布瓦等人的回复。关于“迪克斯特拉等人。1型酪氨酸血症新生儿筛查假阴性——需要重新评估使用琥珀酰丙酮进行的新生儿筛查。2023年，，66”的评论
Int J Neonatal Screen. 2024 Sep 24;10(4):66. doi: 10.3390/ijns10040066.
2
Comment on Dijkstra et al. A False-Negative Newborn Screen for Tyrosinemia Type 1-Need for Re-Evaluation of Newborn Screening with Succinylacetone. 2023, , 66.对迪杰斯特拉等人的评论。1型酪氨酸血症新生儿筛查假阴性——需要重新评估使用琥珀酰丙酮进行的新生儿筛查。2023年，第66期。
Int J Neonatal Screen. 2024 Sep 24;10(4):65. doi: 10.3390/ijns10040065.
3
A False-Negative Newborn Screen for Tyrosinemia Type 1-Need for Re-Evaluation of Newborn Screening with Succinylacetone.1型酪氨酸血症的新生儿筛查假阴性——需要用琥珀酰丙酮重新评估新生儿筛查
Int J Neonatal Screen. 2023 Dec 4;9(4):66. doi: 10.3390/ijns9040066.
4
Reply to Maase et al. Comment on "Jones et al. Application of a Novel Algorithm for Expanding Newborn Screening for Inherited Metabolic Disorders across Europe. 2022, , 20".回复马塞等人。对“琼斯等人。一种用于在欧洲扩大遗传性代谢疾病新生儿筛查的新算法的应用。2022年，，20”的评论。
Int J Neonatal Screen. 2023 Feb 16;9(1):8. doi: 10.3390/ijns9010008.
5
The inclusion of succinylacetone as marker for tyrosinemia type I in expanded newborn screening programs.在扩大的新生儿筛查项目中纳入琥珀酰丙酮作为I型酪氨酸血症的标志物。
Rapid Commun Mass Spectrom. 2008;22(6):812-8. doi: 10.1002/rcm.3428.
6
Newborn screening for hepatorenal tyrosinemia: Tandem mass spectrometric quantification of succinylacetone.肝肾型酪氨酸血症的新生儿筛查：琥珀酰丙酮的串联质谱定量分析
Clin Chem. 2006 Mar;52(3):482-7. doi: 10.1373/clinchem.2005.059790. Epub 2006 Jan 26.
7
Newborn screening for Tyrosinemia type 1 using succinylacetone - a systematic review of test accuracy.使用琥珀酰丙酮对1型酪氨酸血症进行新生儿筛查——检测准确性的系统评价
Orphanet J Rare Dis. 2017 Mar 9;12(1):48. doi: 10.1186/s13023-017-0599-z.
8
[Application of succinylacetone levels measurement in the blood and urine in the diagnosis of tyrosinemia type 1].[血液和尿液中琥珀酰丙酮水平测定在1型酪氨酸血症诊断中的应用]
Zhonghua Er Ke Za Zhi. 2012 Feb;50(2):126-30.
9
Succinylacetone as primary marker to detect tyrosinemia type I in newborns and its measurement by newborn screening programs.琥珀酰丙酮作为检测新生儿I型酪氨酸血症的主要标志物及其在新生儿筛查项目中的测定。
Mol Genet Metab. 2014 Sep-Oct;113(1-2):67-75. doi: 10.1016/j.ymgme.2014.07.010. Epub 2014 Jul 17.
10
Comment on Jones et al. Application of a Novel Algorithm for Expanding Newborn Screening for Inherited Metabolic Disorders across Europe. 2022, , 20.对琼斯等人的评论。一种用于在欧洲扩大遗传性代谢疾病新生儿筛查的新算法的应用。2022年，，20。
Int J Neonatal Screen. 2023 Feb 15;9(1):7. doi: 10.3390/ijns9010007.
本文引用的文献
1
Comment on Dijkstra et al. A False-Negative Newborn Screen for Tyrosinemia Type 1-Need for Re-Evaluation of Newborn Screening with Succinylacetone. 2023, , 66.对迪杰斯特拉等人的评论。1型酪氨酸血症新生儿筛查假阴性——需要重新评估使用琥珀酰丙酮进行的新生儿筛查。2023年，第66期。
Int J Neonatal Screen. 2024 Sep 24;10(4):65. doi: 10.3390/ijns10040065.
2
A False-Negative Newborn Screen for Tyrosinemia Type 1-Need for Re-Evaluation of Newborn Screening with Succinylacetone.1型酪氨酸血症的新生儿筛查假阴性——需要用琥珀酰丙酮重新评估新生儿筛查
Int J Neonatal Screen. 2023 Dec 4;9(4):66. doi: 10.3390/ijns9040066.
3
Maleic acid is a biomarker for maleylacetoacetate isomerase deficiency; implications for newborn screening of tyrosinemia type 1.马来酸是马来酰乙酰乙酸异构酶缺乏症的生物标志物；对酪氨酸血症 1 型新生儿筛查的影响。
J Inherit Metab Dis. 2023 Nov;46(6):1104-1113. doi: 10.1002/jimd.12669. Epub 2023 Aug 10.
Zotero 插件